A Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Naproxen for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip
A patient must meet the following criteria to be eligible for inclusion in the study:
1. Male and female patients, at least 18 years of age, at screening
2. A clinical diagnosis of osteoarthritis
3. Chronic moderate-to-severe knee and/or hip pain
4. Willing to discontinue current pain medications and to adhere to study requirements for rescue treatments
5. A history of non-steroidal anti-inflammatory drug (e.g. Advil, Motrin, Ibuprofen) use for knee and/or hip pain due to osteoarthritis for at least the last 12 weeks
6. Willing to undergo MRI scans and X-rays
7. Willing to maintain current activity and exercise levels throughout the study
8. Willing to complete all study-related questionnaires